Chief Financial Officer Analysts Brian Klein - Stifel Graig Suvannavejh - MLV George Zavoico - H.C. Wainwright Nick Abbott - BMO Capital Markets Presentation Operator Good day, and welcome to the Synta Pharmaceuticals Fourth Quarter and Year End 2013 Earnings
Archer Daniels Midland ( ADM +1.9% ) is upgraded to Outperform from Market Perform with a $50 price target at BMO , which believes ADM is in the early stages of a strategic "transformation" that should create earnings upside in H2 2014 and
Alcatel-Lucent ( ALU +0.8% ) has been upgraded to Outperform by BMO . InterActiveCorp ( IACI +1.2% ) has been upgraded to Outperform by Cowen. DuPont Fabros ( DFT -2.3% ) has been cut to
BMO Capital starts Flexion Therapeutics ( FLXN ) at Buy with a $33 price target. The recent IPO closed Friday at $19.26. Post your comment!
By Markus Aarnio : National Bank of Canada ( OTCPK:NTIOF ) provides various financial services to retail, commercial, corporate, and institutional clients primarily in Canada, the United States, and Europe. (click to enlarge) Insider buying during the last 30 days Here is a table of National Bank
Anthony Petrone - Jefferies LLC, Research Division Steve Willoughby - Cleveland Research Company Kaila Krum Joanne K. Wuensch - BMO Capital Markets U.S. Presentation Operator Good day, ladies and gentlemen, and thank you, all, for joining The Cooper
BMO Capital upgrades Biogen ( BIIB ) to Outperform with a price target of $422. Analyst Jim Birchenough cites bullish near-term
ArthoCare ( ARTC ) to Market Perform representing the fifth sell-side downgrade since January. William Blair , Craig-Hallum, BMO Capital and Northcoast Research all rate the company Neutral or Market Perform. Shares are off a fraction on 50% higher volume
competitive positioning could be compromised.With BlackRock, BMO , Vanguard, and Invesco all putting more weight behind their ..... U.S. providers of exchange-traded funds--BlackRock, BMO , Vanguard, and Invesco--have put more weight behind their
By Kenny Yang : The Bank of Nova Scotia ( BNS ), commonly known as Scotiabank or Scotia, started off fiscal 2014 with a solid quarter. The bank reported Q1/14 earnings on Tuesday which matched analysts' estimates despite weakness in its international banking and capital markets divisions. The ...